Hong Kong Stock Exchange

Tigermed Officially Opens International Headquarters in Hong Kong

Retrieved on: 
Friday, August 18, 2023

HONG KONG, Aug. 16, 2023 /PRNewswire/ -- Tigermed (300347.SZ/3347.HK), a leading global Contract Research Organization (CRO) providing integrated research and development solutions for the biopharmaceutical and medical device industry, officially announced the opening of its International Headquarters in Hong Kong, marking an important and exciting step forward on the path of global operation and corporate development.

Key Points: 
  • HONG KONG, Aug. 16, 2023 /PRNewswire/ -- Tigermed (300347.SZ/3347.HK), a leading global Contract Research Organization (CRO) providing integrated research and development solutions for the biopharmaceutical and medical device industry, officially announced the opening of its International Headquarters in Hong Kong, marking an important and exciting step forward on the path of global operation and corporate development.
  • The International Headquarters will enable Tigermed to coordinate and manage global projects more efficiently, drive business expansion, and empower customers on a global scale.
  • In August 2020, Tigermed was listed on the Hong Kong Stock Exchange (HKSE), marking the landing of the company's "A + H" dual-capital platform.
  • The opening of Tigermed International Headquarters in Hong Kong demonstrated its strong commitment to expanding research capability and global reach to build a full-spectrum service platform.

Tigermed Officially Opens International Headquarters in Hong Kong

Retrieved on: 
Thursday, August 17, 2023

HONG KONG, Aug. 17, 2023 /PRNewswire/ -- Tigermed (300347.SZ/3347.HK), a leading global Contract Research Organization (CRO) providing integrated research and development solutions for the biopharmaceutical and medical device industry, officially announced the opening of its International Headquarters in Hong Kong, marking an important and exciting step forward on the path of global operation and corporate development.

Key Points: 
  • HONG KONG, Aug. 17, 2023 /PRNewswire/ -- Tigermed (300347.SZ/3347.HK), a leading global Contract Research Organization (CRO) providing integrated research and development solutions for the biopharmaceutical and medical device industry, officially announced the opening of its International Headquarters in Hong Kong, marking an important and exciting step forward on the path of global operation and corporate development.
  • The International Headquarters will enable Tigermed to coordinate and manage global projects more efficiently, drive business expansion, and empower customers on a global scale.
  • In August 2020, Tigermed was listed on the Hong Kong Stock Exchange (HKSE), marking the landing of the company's "A + H" dual-capital platform.
  • The opening of Tigermed International Headquarters in Hong Kong demonstrated its strong commitment to expanding research capability and global reach to build a full-spectrum service platform.

Tigermed Officially Opens International Headquarters in Hong Kong

Retrieved on: 
Thursday, August 17, 2023

HONG KONG, Aug. 16, 2023 /PRNewswire/ -- Tigermed (300347.SZ/3347.HK), a leading global Contract Research Organization (CRO) providing integrated research and development solutions for the biopharmaceutical and medical device industry, officially announced the opening of its International Headquarters in Hong Kong, marking an important and exciting step forward on the path of global operation and corporate development.

Key Points: 
  • HONG KONG, Aug. 16, 2023 /PRNewswire/ -- Tigermed (300347.SZ/3347.HK), a leading global Contract Research Organization (CRO) providing integrated research and development solutions for the biopharmaceutical and medical device industry, officially announced the opening of its International Headquarters in Hong Kong, marking an important and exciting step forward on the path of global operation and corporate development.
  • The International Headquarters will enable Tigermed to coordinate and manage global projects more efficiently, drive business expansion, and empower customers on a global scale.
  • In August 2020, Tigermed was listed on the Hong Kong Stock Exchange (HKSE), marking the landing of the company's "A + H" dual-capital platform.
  • The opening of Tigermed International Headquarters in Hong Kong demonstrated its strong commitment to expanding research capability and global reach to build a full-spectrum service platform.

JV Article: Precious metals producer Steppe Gold is set for growth as Mongolia is back on investors' radars

Retrieved on: 
Monday, August 7, 2023

STEPPE GOLD

Key Points: 
  • STEPPE GOLD
    Bataa Tumur-Ochir, co-founder and CEO and chairman of Steppe Gold.
  • STEPPE GOLD
    Steppe Gold is the only TSX-listed precious metals producer in Mongolia after Rio Tinto (NYSE: RIO; LSE: RIO; ASX: RIO) acquired Turquoise Hill Resources for US$3.3 billion to simplify its ownership in the world-class Oyu Tolgoi mine.
  • In June, Steppe Gold closed the acquisition of Canadian miner Anacortes Mining Corp. and its Tres Cruces gold project in Peru.
  • While Steppe Gold isn't planning any further expansion into South America in the near future, it does plan to invest in Mongolia.

Nissin Foods Acquires and Contributes Capital to Nissin Vietnam

Retrieved on: 
Thursday, June 29, 2023

HONG KONG, June 29, 2023 - (ACN Newswire) - Nissin Foods Company Limited ("Nissin Foods", together with its subsidiaries, the "Group"; Stock code: 1475) has signed a Capital Transfer Agreement with Nissin Foods Asia Co., Ltd. (the "Vendor"), with the Group agreeing to purchase the Assigned Contributed Capital at the Consideration of approximately USD9.5 million for the Acquisition of Nissin Foods Vietnam Co., Ltd. ("Nissin Vietnam") and contribute USD2.0 million to the capital of Nissin Vietnam (the "Capital Contribution") after the Acquisition is completed.

Key Points: 
  • HONG KONG, June 29, 2023 - (ACN Newswire) - Nissin Foods Company Limited ("Nissin Foods", together with its subsidiaries, the "Group"; Stock code: 1475) has signed a Capital Transfer Agreement with Nissin Foods Asia Co., Ltd. (the "Vendor"), with the Group agreeing to purchase the Assigned Contributed Capital at the Consideration of approximately USD9.5 million for the Acquisition of Nissin Foods Vietnam Co., Ltd. ("Nissin Vietnam") and contribute USD2.0 million to the capital of Nissin Vietnam (the "Capital Contribution") after the Acquisition is completed.
  • Nissin Vietnam manufactures and distributes instant noodles, and imports and exports instant noodles and other food products.
  • Nissin Vietnam owns and operates an instant noodles factory covering an area of approximately 60,000-square-metre in Binh Duong Province, Vietnam.
  • With control over Nissin Vietnam, Nissin Foods will be able to expand its business footprint geographically and enjoy greater flexibility in deploying production capabilities in Vietnam to respond to increasing market demand and the changing business environment.

Laekna, a Biotechnology Company in China, Listed on the Main Board of the Hong Kong Stock Exchange

Retrieved on: 
Thursday, June 29, 2023

HONG KONG, June 29, 2023 - (ACN Newswire) - A biotechnology company in China - Laekna, Inc. (stock code: 2105.HK), today listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "Hong Kong Stock Exchange").

Key Points: 
  • HONG KONG, June 29, 2023 - (ACN Newswire) - A biotechnology company in China - Laekna, Inc. (stock code: 2105.HK), today listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "Hong Kong Stock Exchange").
  • (2) Use for advancing the clinical development and approval of the other Core Product of the Company, LAE002.
  • The Hong Kong Offering also recorded an over-subscription, of approximately 5.81 times of the 6,373,000 shares offered.
  • The Company has established a number of global and regional partnerships with leading pharmaceutical companies, including Novartis and Innovent.

Perfect Medical Announces Annual Results for FY2022/23

Retrieved on: 
Wednesday, June 28, 2023

HONG KONG, June 28, 2023 - (ACN Newswire) - Perfect Medical Health Management Limited (the "Company", Stock Code: 1830.HK), one of the largest aesthetic medical operators in the world, together with its subsidiaries (collectively referred to as the "Group"), is pleased to announce its annual results for the year ended 31 March 2023.

Key Points: 
  • HONG KONG, June 28, 2023 - (ACN Newswire) - Perfect Medical Health Management Limited (the "Company", Stock Code: 1830.HK), one of the largest aesthetic medical operators in the world, together with its subsidiaries (collectively referred to as the "Group"), is pleased to announce its annual results for the year ended 31 March 2023.
  • Together with the interim dividend of HK13.0 cents, the total dividend payout ratio is expected to be 118.6%.
  • In the post-pandemic era, we remained steadfast in our core strategy of "Healthcare + Medical Beauty" to satisfy the individual needs of the consumers.
  • For further information of the Group's FY2022/23 annual results, please refer to the Company's Annual Results Announcement on the Hong Kong Stock Exchange website at: https://www1.hkexnews.hk/listedco/listconews/sehk/2023/0628/202306280033...

Grand Ming Group Holdings Limited Announces Annual Results for the Year Ended 31 March 2023, Reporting a Record-High Revenue and Net Profit

Retrieved on: 
Tuesday, June 20, 2023

HONG KONG, June 20, 2023 - (ACN Newswire) - Grand Ming Group Holdings Limited (the "Company" and together with its subsidiaries, the "Group", stock code: 1271.HK) today announces its annual results for the year ended 31 March 2023 ("FY 2022/23").

Key Points: 
  • HONG KONG, June 20, 2023 - (ACN Newswire) - Grand Ming Group Holdings Limited (the "Company" and together with its subsidiaries, the "Group", stock code: 1271.HK) today announces its annual results for the year ended 31 March 2023 ("FY 2022/23").
  • The consolidated gross profit also increased 31.2 times to $1,987.8 million (FY 2021/22: $61.7 million).
  • Net profit for FY 2022/23 grew by 71.7 times to $1,275.5 million (FY 2021/22: $17.5 million).
  • Mr. Chan Hung Ming, Chairman and Executive Director of Grand Ming Group Holdings concluded, "The year 2023 remains a challenging year for businesses.

Mario Ho, the Chairman of NIP Group, was named one of Fortune China's 40 Under 40 Business Elites

Retrieved on: 
Wednesday, August 9, 2023

BEIJING, Aug. 9, 2023 /PRNewswire/ -- On July 18th, Mario Ho, the Chairman and Co-CEO of NIP Group, was named Fortune China's 40 Under 40 business elites for 2023 as the youngest entrepreneur this year.

Key Points: 
  • BEIJING, Aug. 9, 2023 /PRNewswire/ -- On July 18th, Mario Ho, the Chairman and Co-CEO of NIP Group, was named Fortune China's 40 Under 40 business elites for 2023 as the youngest entrepreneur this year.
  • The business elites featured on the list are the pioneers of their industry and the times.
  • Mario Ho, the Chairman of NIP Group, is among the new generation of Chinese entrepreneurs, exuding the energy and courage of a dynamic leader.
  • After the merger, the combined entity is now known as NIP Group, with Mario Ho assuming the role of Chairman and co-CEO.

Options Chosen as Primary Market Data Provider for GO Markets' Expansion into Asian Markets

Retrieved on: 
Wednesday, August 9, 2023

Options Technology , the leading provider of financial technology and global market data solutions, today announced its selection as the primary market data provider for GO Markets into Asian Markets.

Key Points: 
  • Options Technology , the leading provider of financial technology and global market data solutions, today announced its selection as the primary market data provider for GO Markets into Asian Markets.
  • View the full release here: https://www.businesswire.com/news/home/20230809286840/en/
    Options today announced its selection as the primary market data provider for GO Markets into Asian Markets.
  • GO Markets , as a regulated multi-award-winning global financial services provider, has chosen Options as its underlying market data provider due to its advanced risk monitoring capabilities, efficient market data management, and globally leading infrastructure.
  • “We are delighted to be selected as GO Markets’ primary market data provider for their expansion into the Asian Markets,” said Danny Moore , President and CEO at Options.